Zymeworks Announces Participation in Upcoming Investor Conferences

VANCOUVER, British Columbia, May 13, 2026 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that management will participate in the following upcoming investor conferences: 2026 Stifel Virtual Targeted Oncology Forum: Zymeworks’ management will participate in... The post Zymeworks Announces Participation in Upcoming Investor Conferences appeared first on Montreal Gazette .

Original source: Montreal Gazette